Skip to main content

Mitochondrial diseases: From Genetic factors to tissue-specificity

RYC2020-029544-I

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Incorporación
Call Ramón y Cajal
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE ZARAGOZA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Identification and characterization of a new pathologic mutation in a large Leber hereditary optic neuropathy pedigree

  • Emperador, Sonia
  • Habbane, Mouna
  • López-Gallardo, Ester
  • Del Rio, Alejandro
  • Llobet, Laura
  • Mateo, Javier
  • Sanz-López, Ana María
  • Fernández-García, María José
  • Sánchez-Tocino, Hortensia
  • Benbunan-Ferreiro, Sol
  • Calabuig-Goena, María
  • Narvaez-Palazón, Carlos
  • Fernández-Vega, Beatriz
  • González-Iglesias, Héctor
  • Urreizti, Roser
  • Artuch, Rafael
  • Pacheu-Grau, David
  • Bayona-Bafaluy, Pilar
  • Montoya, Julio
  • Ruiz-Pesini, Eduardo
Most patients suffering from Leber hereditary optic neuropathy carry one of the three classic pathologic mutations, but not all individuals with these genetic alterations develop the disease. There are different risk factors that modify the penetrance of these mutations. The remaining patients carry one of a set of very rare genetic variants and, it appears that, some of the risk factors that modify the penetrance of the classical pathologic mutations may also affect the phenotype of these other rare mutations., This work was supported by grants from Instituto de Salud Carlos III [FIS-PI20/00340 and FIS-PI21/00229] and European Regional Development Fund (FEDER); Ministerio de Ciencia e Innovación [PID2020-116970GA-I00 and RYC2020-029544-I funded by MCIN/AEI/https://doi.org/10.13039/501100011033 and by “ESF Investing in your future”]; Gobierno de Aragón [LMP22_21; Grupos Consolidados B33_23R]; Fundación Mutua Madrileña [MMA]; and Precipita-FECYT crowfunding program [PR194]. CIBERER is an initiative of the ISCIII., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Otros (Other)

Is population frequency a useful criterion to assign pathogenicity to newly described mitochondrial DNA variants?

  • Bayona-Bafaluy, M. Pilar
  • López-Gallardo, Ester
  • Emperador, Sonia
  • Pacheu-Grau, David
  • Montoya, Julio
  • Ruiz-Pesini, Eduardo
Population frequency has been one of the most widely used criteria to help assign pathogenicity to newly described mitochondrial DNA variants. However, after sequencing this molecule in thousands of healthy individuals, it has been observed that a very large number of genetic variants have a very low population frequency, which has raised doubts about the utility of this criterion. By analyzing the genetic variation of mitochondrial DNA-encoded genes for oxidative phosphorylation subunits in 195,983 individuals from HelixMTdb that were not sequenced based on any medical phenotype, we show that rare variants are deleterious and, along with other criteria, population frequency is still a useful criterion to assign pathogenicity to newly described variants.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Toxic and nutritional factors trigger Leber hereditary optic neuropathy due to a mitochondrial tRNA mutation

  • Vela-Sebastián, Ana
  • López-Gallardo, Ester
  • Emperador, Sonia
  • Hernández-Ainsa, Carmen
  • Pacheu-Grau, David
  • Blanco, Ignacio
  • Ros, Andrea
  • Pascual-Benito, Ester
  • Rabaneda-Lombarte, Neus
  • Presas-Rodríguez, Silvia
  • García-Robles, Pilar
  • Montoya, Julio
  • Ruiz-Pesini, Eduardo
Leber hereditary optic neuropathy is a mitochondrial disease mainly due to pathologic mutations in mitochondrial genes related to the respiratory complex I of the oxidative phosphorylation system. Genetic, physiological, and environmental factors modulate the penetrance of these mutations. We report two patients suffering from this disease and harboring a m.15950G > A mutation in the mitochondrial DNA-encoded gene for the threonine transfer RNA. We also provide evidences supporting the pathogenicity of this mutation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Mitochondrial genetic background may impact statins side effects and atherosclerosis development in familial hypercholesterolemia

  • Ruiz Pesini, Eduardo
  • Bayona Bafaluy, María Pilar
  • Sanclemente, Teresa
  • Puzo, José
  • Montoya, Julio
  • Pacheu Grau, David
Heredity of familial hypercholesterolemia (FH) can present as a dominant monogenic disorder of polygenic origin or with no known genetic cause. In addition, the variability of the symptoms among individuals or within the same families evidence the potential contribution of additional factors than monogenic mutations that could modulate the development and severity of the disease. In addition, statins, the lipid-lowering drugs which constitute the first-line therapy for the disease, cause associated muscular symptoms in a certain number of individuals. Here, we analyze the evidence of the mitochondrial genetic variation with a special emphasis on the role of CoQ10 to explain this variability found in both disease symptoms and statins side effects. We propose to use mtDNA variants and copy numbers as markers for the cardiovascular disease development of FH patients and to predict potential statin secondary effects and explore new mechanisms to identify new markers of disease or implement personalized medicine strategies for FH therapy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A microscopy-based screen identifies cellular kinases modulating mitochondrial translation

  • Yousefi, Roya
  • Cruz-Zaragoza, Luis Daniel
  • Valpadashi, Anusha
  • Hansohn, Carina
  • Dahal, Drishan
  • Richter-Dennerlein, Ricarda
  • Rizzoli, Silvio
  • Urlaub, Henning
  • Rehling, Peter
  • Pacheu-Grau, David
Mitochondrial DNA encodes 13 subunits of the oxidative phosphorylation (OXPHOS) system, which are synthesized inside the organelle and essential for cellular energy supply. How mitochondrial gene expression is regulated and integrated into cellular physiology is little understood. Here, we perform a high-throughput screen combining fluorescent labeling of mitochondrial translation products with small interfering RNA (siRNA)-mediated knockdown to identify cellular kinases regulating translation. As proof of principle, the screen identifies known kinases that affect mitochondrial translation, and it also reveals several kinases not yet linked to this process. Among the latter, we focus on the primarily cytosolic kinase, fructosamine 3 kinase (FN3K), which localizes partially to the mitochondria to support translation. FN3K interacts with the mitochondrial ribosome and modulates its assembly, thereby affecting translation. Overall, our work provides a reliable approach to identify protein functions for mitochondrial gene expression in a high-throughput manner.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Assessment of CoQ10 dietary intake in a mediterranean cohort of familial hypercholesterolemia patients: a pilot study

  • Sanclemente, Teresa
  • Carazo, Alicia
  • Silvestre-Muñoz, Tania
  • Montoya, Julio
  • Ruiz-Pesini, Eduardo
  • Puzo, José
  • Pacheu-Grau, David
Background/Objectives: Coenzyme Q 10 is a lipid molecule that works as a mobile electron transporter in the mitochondrial respiratory chain and, in addition, plays the role of an antioxidant. Interestingly, CoQ10 synthesis in human cells derives from the mevalonate pathway, the same metabolic route that delivers endogenous cholesterol. Mutations leading to Familial Hypercholesterolemia (FH) alter the levels of CoQ10 production and remarkably, statin therapy associated muscular symptoms (SAMSs) might also be modulated by CoQ10 supplementation. CoQ10 is also provided by diet and only a few studies have calculated the dietary intake of this metabolite among populations. Methods: Here, we present our Spanish FH cohort (n = 261) and characterized relevant clinical, metabolic, and anthropometric parameters. Results: A cohort of 75.1% followed lipid-lowering treatment at inclusion, being the most prescribed drugs statin alone (32.7%) and statins combined with ezetimibe (56.6%). The average time on statin treatment was 3.7 years. Interestingly, 22% of cohort patients presented with SAMS. In addition, we performed an exhaustive literature review to define for the first time the CoQ10 content present in food typically found in Spain or other southern-European countries and classified them from very rich (over 50 mg/kg) to very poor (<1 mg/kg). With this information, we calculated the daily intake of CoQ10 from a small group (12) of selected FH patients using a validated food-frequency questionnaire (FFQ) and determined a daily intake 9.72 ± 2.64 mg/day, different to other described populations. Conclusions: we discussed the relevance of exogenous CoQ10 for FH development and potential SAMS. Interestingly, this information can be extrapolated to define the regular CoQ10 intake of the Spanish population, especially when following the MedDiet.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

ISR pathway contribution to tissue specificity of mitochondrial diseases

  • Vela-Sebastián, Ana
  • Bayona-Bafaluy, Pilar
  • Pacheu-Grau, David
Mitochondrial genetic defects caused by whole-body mutations typically affect different tissues in different ways. Elucidating the molecular determinants that cause certain cell types to be primarily affected has become a critical research target within the field. We propose a differential activation of the integrated stress response as a potential contributor to this tissue specificity.